Skip to content

The efficacy of bifidobacteria in the lactational mastitis

The efficacy of bifidobacteria in the lactational mastitis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900021645
Enrollment
Unknown
Registered
2019-03-02
Start date
2019-03-01
Completion date
Unknown
Last updated
2019-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lactational Mastitis

Interventions

Group 1:breast massage
Group 2:antibiotics and breast massage
Group 3:bifidobacteria and breast massage
Group 4:antibiotics, bifidobacteria and breast massage

Sponsors

China-Japan Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Breast-feeding non-suppurative mastitis patients without chronic complications. 1. the temperature >37.2 degree C at the time of enrollment without other reason caused fever; 2. Local congestion,hyperemia, swelling and induration appeared in the breasts, with elevated skin temperature and pain; 3. signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. The patient received other probiotics within 1 month and other therapy; 2. Patient with suppurative mastitis; 3. The patient with other serious basic diseases,such as liver and kidney insufficiency, psychiatric diseases, etc.; 4. Patient allergic to cephalosporin and penicillin.

Design outcomes

Primary

MeasureTime frame
blood;faeces;breast milk;vaginal discharge;baby faeces;

Countries

China

Contacts

Public ContactJiaoying Chen

China-Japan Friendship Hospital

cjy19781031@163.com+86 13146083609

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026